Details for New Drug Application (NDA): 071057
✉ Email this page to a colleague
NDA 071057 describes IBU-TAB 200, which is a drug marketed by Alra and is included in one NDA. Additional details are available on the IBU-TAB 200 profile page.
The generic ingredient in IBU-TAB 200 is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in IBU-TAB 200 is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and thirty-nine suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 071057
| Tradename: | IBU-TAB 200 |
| Applicant: | Alra |
| Ingredient: | ibuprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071057
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Aug 11, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
